Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.

about

Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder

P2860

Q57172126-FD607259-5240-4328-88E9-4EF2C2970639

P2860

Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.

Item

http://www.wikidata.org/entity/Q47665395

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@en

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@nl

type

Item

label

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@en

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@nl

prefLabel

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@en

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@nl

P1476

Augmenting Prolonged Exposure ...... lacebo-controlled pilot trial.

@en

P2093

Amy Wahlquist

http://www.w3.org/2001/XMLSchema#string

Julianne C Flanagan

http://www.w3.org/2001/XMLSchema#string

Lauren M Sippel

http://www.w3.org/2001/XMLSchema#string

Megan M Moran-Santa Maria

http://www.w3.org/2001/XMLSchema#string

Sudie E Back

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review

Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Biological studies of post-traumatic stress disorder.

Effects of systemic administration of oxytocin on contextual fear extinction in a rat model of post-traumatic stress disorder.

Oxytocin facilitates social approach behavior in women.

A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.

The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample

A cognitive model of posttraumatic stress disorder.

Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

P304

64-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPSYCHIRES.2017.12.014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29294429

http://www.w3.org/2001/XMLSchema#string

P921

oxytocin

post-traumatic stress disorder

placebo

P932

5800951

http://www.w3.org/2001/XMLSchema#string

Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.

about

P2860

P2860

Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932